HOME >> MEDICINE >> NEWS
Performing surgery on a beating heart may be safer

Glasgow, Scotland January 31, 2007 - According to a review of the latest clinical trials, coronary artery bypass surgery performed on a beating heart, without the aid of a heart-lung machine, is a safe option that leads to fewer negative side effects for bypass patients. This review is featured in Journal of Cardiac Surgery.

Previously, it was more common for doctors to perform artery bypass surgery on the heart by stopping the heart and passing the blood through a heart-lung machine, says author Dr. Shahzad Raja. However, this process frequently leads to whole body inflammation, which includes complications such as brain swelling, heart arrhythmia and infections. According to Raja, performing the surgery on the beating heart, while more technically challenging for the surgeon, keeps these side effects low and allows for a quicker recovery.

If the surgeons are skilled enough to perform the surgery without stopping the heart, it can be offered to high-risk patients who would not be likely to survive the side effects of the traditional stopped-heart method, says Raja. For this reason, quality training needs to be provided for those surgeons who wish to offer this option to their patients.


'"/>

Contact: Sean Wagner
swagner@bos.blackwellpublishing.com
781-388-8550
Blackwell Publishing Ltd.
31-Jan-2007


Page: 1

Related medicine news :

1. HealthGrades study: Bariatric surgery patients have fewer complications at high-volume hospitals
2. Nonsmall cell lung cancer -- chemotherapy before surgery appears better than surgery alone
3. After epilepsy surgery, quality of life related more to seizures than memory
4. Pancreatic surgery riskier for obese patients
5. Second SPORT study shows surgery advantage for spinal stenosis and slipped vertebra
6. Study questions risks of anti-bleeding drug during heart surgery
7. Same-day coronary angiography and surgery safe for many patients
8. Sling surgery is more effective than Burch for bladder control in women
9. Experts debate role of stenting, bypass surgery in left main coronary artery disease
10. Chemotherapy more effective when given before breast cancer surgery
11. Inflammatory system genes linked to cognitive decline after heart surgery

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:7/20/2017)... ... July 20, 2017 , ... ChenMed , a ... joined JenCare Senior Medical Center as Richmond Chief Medical Officer. Dr. ... Medicine, and Associate Chief Medical Officer of Ambulatory Services for the UVA Health System, ...
(Date:7/20/2017)... ... July 20, 2017 , ... Coats ... is pleased to announce their expansion to the Midwest with the establishment of ... Hollis and Ronald Bell, and of counsels, John Peck and Robert Bruns, will ...
(Date:7/20/2017)... ... July 20, 2017 , ... Team Type 1 Foundation, a nonprofit organization ... affected by diabetes, is teaming up with a Microsoft Corp. employee-led hackathon team for ... July 24th. , “Team Type 1’s mission overlaps seamlessly with Microsoft’s mission to ...
(Date:7/20/2017)... (PRWEB) , ... July 20, 2017 , ... ... about the introduction of bipartisan House and Senate legislation in support of providing ... Congresswoman Robin Kelly (D-IL) introduced H.R. 2408, the “Protecting Girls’ Access to Education ...
(Date:7/20/2017)... ... July 20, 2017 , ... TCGRx announced ... its existing adherence automation lines. The ATP® Mini and InspectRx® Mini ... TCG’s standard products, but at a size and price point that can help ...
Breaking Medicine News(10 mins):
(Date:7/12/2017)... , July 12, 2017  Eli Lilly and Company (NYSE: ... with generic companies to resolve pending patent litigation in the ... Virginia regarding the Cialis ® (tadalafil) unit ... April 26, 2020. As part of the agreement, Cialis exclusivity ... 27, 2018. "The unit dose patent for Cialis ...
(Date:7/11/2017)... 11, 2017  The global market for liquid biopsy ... $394.1 million in 2016.  Although in early stages, the ... in particular as a result of the gradual shift ... recent introduction of a significant number of new liquid ... of tumor biomarkers to guide treatment decisions. ...
(Date:7/11/2017)... -- Oramed Pharmaceuticals Inc. (NASDAQ: ORMP ) ... the development of oral drug delivery systems, announced today ... agreed to schedule an End-of-Phase II meeting with Oramed ... oral insulin capsule ORMD-0801 in the treatment of type ... secondary endpoints by indicating a statistically significant lowering of ...
Breaking Medicine Technology:
Cached News: